Atlas Trials

CMV-TCIP Directed Letermovir Prophylaxis After Allo-SCT

Clinical trial NCT06453460 · RECRUITING

Trial details

NCT number
NCT06453460
Sponsor
University of California, Irvine
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
CMVAllogeneic Stem Cell Transplantation
Start date
2024-06-27
Primary completion
2028-06-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.